Pete Avalos

Vice President, Market Access and Pricing at Geron

Speaker

Peter Avalos joined Geron in December 2022 from Daiichi Sankyo Inc., where he established a field reimbursement model and hub infrastructure to ensure visibility to key data and metrics to execute a successful launch of the antibody drug conjugate, Enhertu, into the U.S. market. Mr. Avalos has over thirty years of experience working in the healthcare industry across both the drug, medical device, and home health.

He is currently at Geron serving as VP of Market Access & Pricing at Geron Corporation, driving payer strategies, distribution frameworks, and patient affordability solutions for a first-in-class product launch. Key contributions include establishing integrated Patient HUB and GPO channels, enabling seamless patient access within seven months of launch.

Previous company experiences include Walgreens Boots Alliance, Inc., Dendreon Pharmaceuticals LLC, and Johnson & Johnson. Mr. Avalos holds multiple degrees from Seton Hall University, including a B.S. in Business Administration, an M.S. in International Business and an M.B.A. in Finance.